Pharmaceutical compound having inhibitory activity against cholesterol acyltransferase isozyme 2 (ACAT2)

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9896456
SERIAL NO

15320834

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This invention provides a novel non-natural pharmaceutical compound having a different mechanism than statin drugs and having a selective inhibitory activity against ACAT2. This invention relates to the compound represented by Formula (I), a salt thereof, or a solvate thereof:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SCHOOL JURIDICAL PERSON KITASATO INSTITUTETOKYO 108-8641

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Nagamitsu, Tohru Sagamihara, JP 8 33
Ohtawa, Masaki Sagamihara, JP 2 2
Omura, Satoshi Sagamihara, JP 102 462
Tomoda, Hiroshi Sagamihara, JP 44 171

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 20, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 20, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00